Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
Dihydroartemisinin piperaquine
United Therapeutics Europe Ltd
Malaria
1 trial -
Docetaxel
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Doxycycline
Jian Li
Amyloidosis; Systemic
1 trial -
Drug
The First People's Hospital of Lianyungang
Herpes Zoster
1 trial -
Du-Huo-Ji-Sheng-Tang (DHJST)
Chinese University of Hong Kong
Knee Osteoarthritis
1 trial -
Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
The First People's Hospital of Lianyungang
Diabetes
1 trial -
Dynamometric tension assessment
The First People's Hospital of Lianyungang
Incisional Hernia
1 trial -
EAA
United Therapeutics Europe Ltd
Military Operational Stress Reaction
1 trial -
EAA+W & Carbohydrate
United Therapeutics Europe Ltd
Energy Deficit
1 trial -
ESC 0/1 hour troponin pathway
NORTHWEST BIOTHERAPEUTICS INC
Acute Coronary Syndrome
1 trial -
ET-01
Guangzhou Virotech Pharmaceutical Co.,
Transfusion Dependent Beta-Thalassaemia
1 trial -
ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer
United Therapeutics Europe Ltd
Healthy Volunteer
1 trial -
EVM18001 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
System Lupus Erythematosus(SLE)
1 trial -
Early Nutrition Intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nutrition
1 trial -
Early auto-mode
Century Therapeutics
Diabetes Mellitus Type 1 Pre-Existing
1 trial -
EchoGo
United Therapeutics Europe Ltd
Coronary Heart Disease
1 trial -
Efgartigimod + Telitacicept (1-week interval) group
The First People's Hospital of Lianyungang
Myasthenia Gravis
1 trial -
EmbryoGlue® (laboratory culture medium)
United Therapeutics Europe Ltd
Infertility
1 trial -
Energy Balance
United Therapeutics Europe Ltd
Inflammation
1 trial -
Entecavir
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Entecavir 0.5 mg
The First People's Hospital of Lianyungang
Hepatitis B
1 trial -
Enteral immunonutrition
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Nasopharyngeal Carcinoma
1 trial -
Envita Stories Methodology in Long-term care Centres for old adults
Gain Therapeutics
Long-term Care Centres for Old Adults Users
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources